Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to American Life Science Pharmaceuticals in September, 2018 for $623,350.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS110147-01 | Phase I | 623,350 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $157,550.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA018007-01 | Phase I | 157,550 | ||||||||
A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,541,520.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AG018280-02A1 | Phase II | 1,541,520 | ||||||||
A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $115,137.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG032784-01 | Phase I | 115,137 | ||||||||
A SBIR Phase I contract was awarded to American Life Science Pharmaceuticals for $95,089.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG030865-01A1 | Phase I | 95,089 | ||||||||
A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,148,520.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG032784-02 | Phase II | 1,148,520 | ||||||||
A SBIR Phase II contract was awarded to American Life Science Pharmaceuticals for $1,144,770.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG030865-02 | Phase II | 1,144,770 |